Hedgehog Drug Helps Late-Stage Cancers
Links shared publicly online about this topic.
- 1,777total visits
Hedgehog Drug Helps Late-Stage Cancers
View full resource at webmd.com
Tags: Skin, Brain, Cancer, Brain Cancer, Drug
Most Recently Shared on September 4, 2009 at 5:20 pm By:
Experimental 'Hedgehog' Drug Targets Cancer http://bit.ly/BFYCK
Also Shared By:
New drug helping men with prostate cancer
wndu.com — “A drug being investigated right now could prove to be a big breakthrough for men with late stage prostate cancer, especially in cases where the disease has spread to the bone.” View full resource at wndu.com
Most Recently Shared on April 26, 2012 at 8:41 pm By:
Controversial drug helping men with prostate cancer: A drug being investigated right now could prove to be a big... http://t.co/nx4NHjBJ
Prostate Cancer Drug Improves Survival | ThirdAge
thirdage.com — “A prostate cancer experimental drug from Medivation Inc. helped patients live longer in a late-stage clinical trial, the biotechnology company said Thursday.” View full resource at thirdage.com
Most Recently Shared on November 5, 2011 at 1:58 pm By:
FDA Approves Xalkori With Companion Diagnostic For A Type Of Late-stage Lung Cancer - QualityPoint Technologies
qualitypointtech.net — “The U.S. Food and Drug Administration approved Xalkori (crizotinib) to treat certain patients with late-stage (locally advanced or metastatic), non-small cell lung cancers (NSCLC) who express the abnormal anaplastic lymphoma kinase (ALK) gene. Xalkori is being approved with a companion diagnostic test that will help determine if a patient has the abnormal ALK gene, a first-of-a-kind genetic test called the Vysis ALK Break Apart FISH Probe Kit. It is the second such targeted therapy approved by t” View full resource at qualitypointtech.net
Most Recently Shared on August 27, 2011 at 12:00 pm By:
FDA Approves Xalkori With Companion Diagnostic For A Type Of Late-stage Lung Cancer: The U.S. Food and Drug Admini... http://t.co/6HRx8I6
FDA Approves Xalkori With Companion Diagnostic For A Type Of Late-stage Lung Cancer - QualityPoint Technologies
qualitypointtech.net — “The U.S. Food and Drug Administration approved Xalkori (crizotinib) to treat certain patients with late-stage (locally advanced or metastatic), non-small cell lung cancers (NSCLC) who express the abnormal anaplastic lymphoma kinase (ALK) gene. Xalkori is being approved with a companion diagnostic test that will help determine if a patient has the abnormal ALK gene, a first-of-a-kind genetic test called the Vysis ALK Break Apart FISH Probe Kit. It is the second such targeted therapy approved by t” View full resource at qualitypointtech.net
Most Recently Shared on August 27, 2011 at 9:45 am By:
FDA Approves Xalkori With Companion Diagnostic For A Type Of Late-stage Lung Cancer: The U.S. Food and Drug Admini... http://t.co/Dab3lox
Late-Stage Ovarian Cancer Therapy Shows Promise in Phase II Trial
newswise.com — “An experimental two-drug combination for treating late-stage ovarian cancer continues to produce strong results. Its Indiana U. researchers say they may have discovered biomarkers that could help identify women who would respond best to the therapy.” View full resource at newswise.com
Most Recently Shared on August 2, 2011 at 9:28 pm By:
Late-Stage Ovarian Cancer Therapy Shows Promise in Phase II Trial: An experimental two-drug combination for trea... http://bit.ly/p8pbAx
Late-Stage Ovarian Cancer Therapy Shows Promise in Phase II Trial
newswise.com — “An experimental two-drug combination for treating late-stage ovarian cancer continues to produce strong results. Its Indiana U. researchers say they may have discovered biomarkers that could help identify women who would respond best to the therapy.” View full resource at newswise.com
Most Recently Shared on August 2, 2011 at 4:49 pm By:
Late-Stage Ovarian Cancer Therapy Shows Promise in Phase II Trial: An experimental two-drug combination ... http://bit.ly/qAuA96 #cancer
Novartis Gets Good News on Cancer Drug Afinitor - FoxNews.com
foxnews.com — “Novartis AG said a late-stage study showed its drug hope Afinitor slowed tumor growth in advanced breast cancer, helping its chances of becoming a new blockbuster treatment” View full resource at foxnews.com
Most Recently Shared on July 7, 2011 at 12:48 am By:
Novartis Gets Good News on Cancer Drug Afinitor http://bit.ly/q9WDuK
Novartis gets good news on cancer drug Afinitor | Reuters
reuters.com — “ZURICH (Reuters) - Novartis AG said a late-stage study showed its drug hope Afinitor slowed tumor growth in advanced breast cancer, helping its chances of becoming a new blockbuster treatment.The Swiss” View full resource at reuters.com
Most Recently Shared on July 6, 2011 at 2:37 am By:
News: Novartis gets good news on cancer drug Afinitor http://reut.rs/qk1Cl4 - #health #pharma
Novartis gets good news on cancer drug Afinitor | Reuters
reuters.com — “ZURICH (Reuters) - Novartis AG said a late-stage study showed its drug hope Afinitor slowed tumor growth in advanced breast cancer, helping its chances of becoming a new blockbuster treatment.The Swiss” View full resource at reuters.com
Most Recently Shared on July 5, 2011 at 10:20 pm By:
Novartis gets good news on cancer drug Afinitor http://ow.ly/1dDkGf
Novartis gets good news on cancer drug Afinitor | Reuters
reuters.com — “ZURICH (Reuters) - Novartis AG said a late-stage study showed its drug hope Afinitor slowed tumor growth in advanced breast cancer, helping its chances of becoming a new blockbuster treatment.The Swiss” View full resource at reuters.com
Most Recently Shared on July 5, 2011 at 10:08 pm By:
Novartis gets good news on cancer drug Afinitor http://reut.rs/q4Eu6I
Novartis gets good news on cancer drug Afinitor | Reuters
reuters.com — “ZURICH (Reuters) - Novartis AG said a late-stage study showed its drug hope Afinitor slowed tumor growth in advanced breast cancer, helping its chances of becoming a new blockbuster treatment.The Swiss” View full resource at reuters.com
Most Recently Shared on July 5, 2011 at 9:51 pm By:
Novartis gets good news on cancer drug Afinitor http://bit.ly/omnKML
Chemo for Late-Stage Cancer Patients May Be Unjustified - Drugs.com MedNews
drugs.com — “Some patients with advanced cancer receive drugs that won t help them but could cause them harm, a U.S. study suggests. University of Chicago researchers analyz” View full resource at drugs.com
Most Recently Shared on June 9, 2011 at 10:55 pm By:
Chemo for Late-Stage Cancer Patients May Be Unjustified - http://bit.ly/kDOv7J
Roche's Tarceva helps lung cancer patients | Reuters
reuters.com — “ZURICH (Reuters) - Roche Holding AG's cancer drug Tarceva nearly doubles the time patients with a distinct type of lung cancer live without their disease getting worse, a late-stage trial showed on Friday.The” View full resource at reuters.com
Most Recently Shared on June 4, 2011 at 5:38 am By:
Roche's Tarceva helps lung cancer patients: ZURICH (Reuters) - Roche Holding AG's cancer drug Tarceva nearly dou... http://bit.ly/mzeU6t
Roche's Tarceva helps lung cancer patients | Reuters
reuters.com — “ZURICH (Reuters) - Roche Holding AG's cancer drug Tarceva nearly doubles the time patients with a distinct type of lung cancer live without their disease getting worse, a late-stage trial showed on Friday.The” View full resource at reuters.com
Most Recently Shared on June 3, 2011 at 5:12 pm By:
Roche's Tarceva helps lung cancer patients http://bit.ly/ksFaoc
Roche's Tarceva helps lung cancer patients | Reuters
reuters.com — “ZURICH (Reuters) - Roche Holding AG's cancer drug Tarceva nearly doubles the time patients with a distinct type of lung cancer live without their disease getting worse, a late-stage trial showed on Friday.The” View full resource at reuters.com
Most Recently Shared on June 3, 2011 at 4:46 pm By:
Roche's Tarceva helps lung cancer patients http://reut.rs/iMJPdG
Advertisement



Heart Health
@HeartsHealth
webMD: Hedgehog Drug Helps Late-Stage Cancers http://bit.ly/D9cFh Full http://bit.ly/NiWZv
1 year ago...